# Acrivon Therapeutics (ACRV) — Analyst Forecast

ACRV · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/acrv/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Jan 9, 2026 | Piper Sandler | Maintained | Overweight | $8.00 |
| Nov 25, 2025 | HC Wainwright & Co. | Maintained | Buy | $19.00 |
| Aug 14, 2025 | Oppenheimer | Maintained | Outperform | $8.00 |
| May 16, 2025 | Jones Trading | Downgraded | Buy → Hold | — |
| May 15, 2025 | Oppenheimer | Maintained | Outperform | $9.00 |
| Mar 28, 2025 | HC Wainwright & Co. | Maintained | Buy | $19.00 |
| Mar 26, 2025 | HC Wainwright & Co. | Maintained | Buy | $19.00 |
| Mar 26, 2025 | Cantor Fitzgerald | Maintained | Overweight | — |
| Mar 26, 2025 | Citizens Capital Markets | Maintained | Market Outperform | $17.00 |
| Jan 31, 2025 | Cantor Fitzgerald | Initiated Coverage | Overweight | — |
| Nov 14, 2024 | HC Wainwright & Co. | Maintained | Buy | $22.00 |
| Nov 14, 2024 | BMO Capital | Maintained | Outperform | $27.00 |
| Sep 16, 2024 | HC Wainwright & Co. | Maintained | Buy | $22.00 |
| Sep 16, 2024 | BMO Capital | Maintained | Outperform | $28.00 |
| Sep 16, 2024 | Ladenburg Thalmann | Upgraded | Neutral → Buy | $16.00 |
| Sep 16, 2024 | JMP Securities | Maintained | Market Outperform | $17.00 |
| Aug 13, 2024 | HC Wainwright & Co. | Maintained | Buy | $22.00 |
| May 15, 2024 | BMO Capital | Maintained | Outperform | $25.00 |
| May 14, 2024 | HC Wainwright & Co. | Maintained | Buy | $22.00 |
| Apr 29, 2024 | Ladenburg Thalmann | Downgraded | Buy → Neutral | — |

## Frequently Asked Questions

### What is the latest analyst rating on ACRV?

On Jan 9, 2026, Piper Sandler maintained Acrivon Therapeutics at Overweight with a price target of $8.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).